FDA Clearance Tracker · P080004-S028
IPure Preloaded IOL System
Last checked: Nov 20, 2026Latest source record: Apr 23, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Apr 23, 2020
Approved
Time to decision
143 days
Received Dec 2, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080004-S028
- Device name
- IPure Preloaded IOL System
- Applicant
- Hoya Surgical Optics, Inc.
- Applicant location
- Chino Hills, CA
- Received
- Dec 2, 2019
- Decided
- Apr 23, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P080004
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for packaging changes for the iSert® Preloaded System Platform Models 230 and 231. The device, as modified, will be marketed under the trade name IPure Preloaded IOL System Model B3PC and B3PY.
Source documents
Other decisions for Hoya Surgical Optics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.